1
|
Sorushanova A, Delgado LM, Wu Z, Shologu N, Kshirsagar A, Raghunath R, Mullen AM, Bayon Y, Pandit A, Raghunath M, Zeugolis DI. The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2019; 31:e1801651. [PMID: 30126066 DOI: 10.1002/adma.201801651] [Citation(s) in RCA: 476] [Impact Index Per Article: 95.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Revised: 06/03/2018] [Indexed: 05/20/2023]
Abstract
Collagen is the oldest and most abundant extracellular matrix protein that has found many applications in food, cosmetic, pharmaceutical, and biomedical industries. First, an overview of the family of collagens and their respective structures, conformation, and biosynthesis is provided. The advances and shortfalls of various collagen preparations (e.g., mammalian/marine extracted collagen, cell-produced collagens, recombinant collagens, and collagen-like peptides) and crosslinking technologies (e.g., chemical, physical, and biological) are then critically discussed. Subsequently, an array of structural, thermal, mechanical, biochemical, and biological assays is examined, which are developed to analyze and characterize collagenous structures. Lastly, a comprehensive review is provided on how advances in engineering, chemistry, and biology have enabled the development of bioactive, 3D structures (e.g., tissue grafts, biomaterials, cell-assembled tissue equivalents) that closely imitate native supramolecular assemblies and have the capacity to deliver in a localized and sustained manner viable cell populations and/or bioactive/therapeutic molecules. Clearly, collagens have a long history in both evolution and biotechnology and continue to offer both challenges and exciting opportunities in regenerative medicine as nature's biomaterial of choice.
Collapse
Affiliation(s)
- Anna Sorushanova
- Regenerative, Modular and Developmental Engineering Laboratory (REMODEL), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
- Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
| | - Luis M Delgado
- Regenerative, Modular and Developmental Engineering Laboratory (REMODEL), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
- Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
| | - Zhuning Wu
- Regenerative, Modular and Developmental Engineering Laboratory (REMODEL), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
- Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
| | - Naledi Shologu
- Regenerative, Modular and Developmental Engineering Laboratory (REMODEL), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
- Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
| | - Aniket Kshirsagar
- Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
| | - Rufus Raghunath
- Centre for Cell Biology and Tissue Engineering, Competence Centre Tissue Engineering for Drug Development (TEDD), Department Life Sciences and Facility Management, Institute for Chemistry and Biotechnology (ICBT), Zürich University of Applied Sciences, Wädenswil, Switzerland
| | | | - Yves Bayon
- Sofradim Production-A Medtronic Company, Trevoux, France
| | - Abhay Pandit
- Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
| | - Michael Raghunath
- Centre for Cell Biology and Tissue Engineering, Competence Centre Tissue Engineering for Drug Development (TEDD), Department Life Sciences and Facility Management, Institute for Chemistry and Biotechnology (ICBT), Zürich University of Applied Sciences, Wädenswil, Switzerland
| | - Dimitrios I Zeugolis
- Regenerative, Modular and Developmental Engineering Laboratory (REMODEL), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
- Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland
| |
Collapse
|
2
|
Peterson AA, Lachance RP, Tester JW. Kinetic Evidence of the Maillard Reaction in Hydrothermal Biomass Processing: Glucose−Glycine Interactions in High-Temperature, High-Pressure Water. Ind Eng Chem Res 2010. [DOI: 10.1021/ie9014809] [Citation(s) in RCA: 133] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Andrew A. Peterson
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA
| | - Russell P. Lachance
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA
| | - Jefferson W. Tester
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA
| |
Collapse
|
3
|
Robert L. An Original Approach to Aging: An Appreciation of Fritz Verzár’s Contribution in the Light of the Last 50 Years of Gerontological Facts and Thinking. Gerontology 2006; 52:268-74. [PMID: 16974097 DOI: 10.1159/000094607] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2006] [Indexed: 11/19/2022] Open
Abstract
The motivation of this review is the 120th anniversary of the birth of Fritz Verzár, founder of experimental gerontology. His major contributions to aging research are shortly reviewed and re-evaluated in the light of modern gerontological research. Verzár undertook aging research after his retirement from the Chair of Physiology at the Medical Faculty of Basel. His first experiments on aging of the rat tail tendon revealed an important mechanism of aging: an exponential increase of cross-linking of collagen fibres. This observation, correctly interpreted by Verzár as a new age-dependent mechanism, was shown later to be attributed to the Maillard reaction, the non-enzymatic glycosylation of protein (and nucleotide bases) amino groups followed by evolution of the reaction to advanced glycation end products (AGEs) involved in a number of harmful reactions. Many of these reactions were shown to be mediated by receptors recognizing AGE products (RAGEs). This was the first example of a post-synthetic (post-translational) reaction involved in the aging of biological macromolecules, especially those of the extracellular matrix. Verzár extended the research activity of his team to several other aspects of aging research, such as loss of muscular strength, nutritional requirements at high altitude, cell loss with aging, and ultrastructural studies, and started also the first longitudinal clinical study of aging in a Basel population. Modern gerontological research confirmed and extended Verzár's observations. His work on collagen cross-linking by glycation became of paramount importance in recent times because of the rapid increase of diabetes type II, combined with the metabolic syndrome, one of the major pathologies of modern times.
Collapse
Affiliation(s)
- Ladislas Robert
- Laboratoire de Recherche Ophtalmologique, Hôtel-Dieu, Université Paris 5, Paris, France.
| |
Collapse
|
4
|
Robert L. Fritz Verzár was born 120 years ago: his contribution to experimental gerontology through the collagen research as assessed after half a century. Arch Gerontol Geriatr 2006; 43:13-43. [PMID: 16764955 DOI: 10.1016/j.archger.2006.02.007] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2005] [Revised: 02/20/2006] [Accepted: 02/27/2006] [Indexed: 11/15/2022]
Abstract
F. Verzár's experiments on the age-dependent increase of cross-linking of rat tail tendons in the 1950s represented the first demonstration of age-dependent modifications of extracellular matrix (ECM) macromolecules. This discovery preceded by several years the demonstration of cell-aging and showed that body constituents considered as metabolically "inert" do exhibit age-dependent modifications at the molecular level. Progressively the physiological mechanisms of collagen cross-linking were elucidated and it became clear that this mechanism does not explain the Verzár phenomenon. It was progressively elucidated that the Maillard reaction was involved in the age-dependent cross-linking of collagen. The role of advanced glycation end products (AGEs) in collagen cross-linking, as well as their reaction with other macromolecules was convincingly demonstrated as an important factor of age-dependent modifications of cells and tissues. The Verzár phenomenon completed by the detailed chemistry of the Maillard reaction became thus a dominant paradigm in tissue aging. Verzár's name and discovery should therefore remain associated with these important progresses in aging research. The purpose of this review is to recall some of the details of Verzár's work which paved the way to his discovery and extended well beyond collagen aging.
Collapse
Affiliation(s)
- Ladislas Robert
- Laboratoire de Recherche Ophtalmologique, Hôtel-Dieu, Université Paris 5, 1 place du parvis Notre Dame, 75181 Paris Cedex 04, France.
| |
Collapse
|